Diagnostig Limited was established in 2012 as a Point of Care (PoC) diagnostics company. The company is a spin-out from Bangor University and has technology that focuses on novel devices for the diagnosis of Mycobacterial infections (including Tuberculosis) using a proprietary lipid technology. Diagnostig’s core technology is based on the manufacture of specific mycolic acids which are components of the cell walls of mycobacteria.
You are here: Home › Team Services is working with Diagnostig Ltd to commercialise a novel diagnostic technology.
Comments are closed.